Cognios Beta Neutral Large Cap Fund, LP
- SEC CIK
- 0001538882
- Latest filing
- May 8, 2024
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Cognios Beta Neutral Large Cap Fund, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q1 2024 holdings
- Shares (Q1 2024)
- 560
- Value
- $539.0K
- % of portfolio
- 0.7%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 560 | $539.0K | 0.7% | −118−17.4% | Reduced | Holders |
| Q4 2023 | 678 | $595.5K | 0.8% | −67−9.0% | Reduced | Holders |
| Q3 2023 | 745 | $613.1K | 0.8% | −194−20.7% | Reduced | Holders |
| Q2 2023 | 939 | $674.7K | 0.8% | −449−32.3% | Reduced | Holders |
| Q1 2023 | 1,388 | $1.13M | 1.1% | +17+1.2% | Added | Holders |
| Q4 2022 | 1,371 | $989.2K | 0.9% | – | No prior filing | Holders |